301230.SZ
PharmaResources (Shanghai) Co., Ltd
SZSE · M 科研服务 · CN
CNY 33.84
−5.26%Margins
Gross margin
28.3%
EBITDA margin
14.5%
EBIT margin
6.4%
Net margin
6.7%
FCF margin
16.3%
4.5%
Return on equity
3.5%
Return on assets
3.8%
Return on invested capital
0.53x
Asset turnover
CNY 167.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026